
Currently out of the existing stock ratings of Kemp Dolliver, 25 are a BUY (89.29%), 3 are a HOLD (10.71%).
Analyst Kemp Dolliver, currently employed at BROOKLINE, has had 48.48% of price targets met with an average potential upside of 54.27%, reached in 139 days on average.
Kemp Dolliver has documented 51 price targets and ratings displayed on 15 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on LNTH, at 09-Apr-2026.
Analyst best performing recommendations are on MNPR.
The best stock recommendation documented was for MNPR on 9/25/2025. The price target of $93 was fulfilled within 7 days with a profit of $15.56 (20.09%), with a performance score of 28.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Mar-2020
$18
$13.58 (307.24%)
$18
8 months 2 days ago
(20-Mar-2026)
7/12 (58.33%)
$11.75 (188.00%)
382
Buy Since 27-Jul-2021
$26
$45
1 years 8 months 9 days ago
(13-Mar-2025)
0/2 (0%)
$16.45 (172.25%)
Buy Since 13-Jan-2023
$18.75
3 years 10 months 9 days ago
(13-Jan-2023)
1/1 (100%)
$14.22 (313.91%)
768
Buy Since 30-Sep-2020
$22.5
$45
4 years 8 months 11 days ago
(11-Mar-2022)
1/2 (50%)
$14.32 (175.06%)
118
Hold Since 14-Aug-2020
$52.5
6 years 3 months 8 days ago
(14-Aug-2020)
0/2 (0%)
$18.45 (54.19%)
Stocks Kemp Dolliver covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.
What Year was the first public recommendation made by Kemp Dolliver?